Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection;L'impact des microARN dans la pathogenèse et le traitement de l'infection par le virus de l'hépatite C

Gastroenterologie Clinique et Biologique

Volumn 34, Issue 8-9, 2010, Pages 431-435

  Pfeffer, S ^a   Baumert, T F ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b HÔPITAL CIVIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MICRORNA;

HEPATITIS C; HEPATITIS C VIRUS; PATHOGENESIS; RNA INTERFERENCE; SHORT SURVEY; VIRUS LOAD;

HEPACIVIRUS; HEPATITIS C; HUMANS; MICRORNAS; RNA INTERFERENCE;

EID: 77957151975     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2010.04.010     Document Type: Short Survey

References (37)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
2. Benga W.J., Krieger S.E., Dimitrova M., Zeisel M.B., Parnot M., Lupberger J., et al. Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles. Hepatology 2010, 51(1):43-53.
3. Chang J.H., Cruo J.T., Jiang D., Guo H.T., Taylor J.M., Block T.M. Liver-specific micro-RNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J Virol 2008, 82(16):8215-8223.
4. Elmen J., Lindow M., Schutz S., Lawrence M., Petri A., Obad S., et al. LNA-mediated micro-RNA silencing in nonhuman primates. Nature 2008, 452(7189):896-899.
5. Elmen J., Lindow M., Silahtaroglu A., Bak M., Christensen M., Lind-Thomsen A., et al. Antagonism of micro-RNA-122 in mice by systemically administered LNA-antimi-R leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008, 36(4):1153-1162.
6. Fire A., Xu S.Q., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391(6669):806-811.
7. Gottwein E., Cullen B.R. Viral and cellular micro-RNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 2008, 3(6):375-387.
8. Henke J.I., Goergen D., Zheng J., Song Y., Schuttler C.G., Fehr C., et al. Micro-RNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 2008, 27(24):3300-3310.
9. Hezode C., Forestier N., Dusheiko G., Ferenci P., Pol S., Goeser T., et al. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. N Engl J Med 2009, 360(18):1839-1850.
10. Hou W., Tian Q., Zheng J., Bonkovsky H.L. Micro-RNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins. Hepatology 2009.
11. Iorio M.V., Croce C.M. Micro-RNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009, 27(34):5848-5856.
12. Jackson D.B. Serum-based micro-RNAs: are we blinded by potential?. Proc Natl Acad Sci U S A 2009, 106(1):E5.
13. Ji J., Shi J., Budhu A., Yu Z., Forgues M., Roessler S., et al. Micro-RNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009, 361(15):1437-1447.
14. Jopling C.L., Norman K.L., Sarnow P. Positive and negative modulation of viral and cellular mRNAs by liver-specific micro-RNA miR-122. Cold Spring Harb Symp Quant Biol 2006, 71:369-376.
15. Jopling C.L., Yi M.K., Lancaster A.M., Lemon S.M., Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific micro-RNA. Science 2005, 309(5740):1577-1581.
16. Krieger S.E., Zeisel M.B., Davis C., Thumann C., Harris H.J., Schnober E.K., et al. Inhibition of hepatitis C virus infection by anticlaudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations. Hepatology 2009.
17. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., et al. Silencing of micro-RNAs in vivo with 'antagomirs'. Nature 2005, 438(7068):685-689.
18. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., Persson R., Lindow M., Munk M.E., et al. Therapeutic silencing of micro-RNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327(5962):198-201.
19. Liu S., Yang W., Shen L., Turner J.R., Coyne C.B., Wang T. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J Virol 2009, 83(4):2011-2014.
20. Liu X.Y., Wang T.Y., Wakita T., Yang W. Systematic identification of micro-RNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Virology 2010, 398(1):57-67.
21. Marcellin P., Bourliere M., Pawlotsky J.M., Ouzan D. HCV nonresponder patients: definition of nonresponse and treatment strategy. Gastroenterol Clin Biol 2007, 31(8-9 Pt 3). 4S13-19.
22. Meister G., Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature 2004, 431(7006):343-349.
23. Murakami Y., Aly H.H., Tajima A., Inoue I., Shimotohno K. Regulation of the hepatitis C virus genome replication by miR-199a. J Hepatol 2009, 50(3):453-460.
24. Napoli C., Lemieux C., Jorgensen R. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 1990, 2(4):279-289.
25. Niepmann M. Activation of hepatitis C virus translation by a liver-specific micro-RNA. Cell Cycle 2009, 8(10):1473-1477.
26. Norman K.L., Sarnow P. Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by micro-RNA miR-122 involves distinct mechanisms. J Virol 2010, 84(1):666-670.
27. Parameswaran P., Sklan E., Wilkins C., Burgon T., Samuel M.A., Lu R., et al. Six RNA viruses and 41 hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog 2010, 6(2):e1000764.
28. Pedersen I.M., Cheng G., Wieland S., Volinia S., Croce C.M., Chisari F.V., et al. Interferon modulation of cellular micro-RNAs as an antiviral mechanism. Nature 2007, 449(7164). 919-U913.
29. Pfeffer S., Baumert T.F. Unravelling the importance of micro-RNAs during hepatitis C virus infection in the human liver. J Hepatol 2009, 51(3):606-609.
30. Pfeffer S., Baumert T.F. Antagonizing microRNA-122 and treatment of hepatitis C virus infection. Hepatology 2010, 51(4):1461-1463.
31. Pfeffer S., Sewer A., Lagos-Quintana M., Sheridan R., Sander C., Grasser F.A., et al. Identification of micro-RNAs of the herpes virus family. Nat Methods 2005, 2(4):269-276.
32. Pfeffer S., Zavolan M., Grasser F.A., Chien M.C., Russo J.J., Ju J.Y., et al. Identification of virus-encoded micro-RNAs. Science 2004, 304(5671):734-736.
33. Sarasin-Filipowicz M., Krol J., Markiewicz I., Heim M.H., Filipowicz W. Decreased levels of micro-RNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 2009, 15(1):31-33.
34. Tai A.W., Chung R.T. Treatment failure in hepatitis C: mechanisms of nonresponse. J Hepatol 2009, 50(2):412-420.
35. Ura S., Honda M., Yamashita T., Ueda T., Takatori H., Nishino R., et al. Differential micro-RNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009, 49(4):1098-1112.
36. Zeisel M.B., Barth H., Schuster C., Baumert T.F. Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy. Front Biosci 2009, 14:3274-3285.
37. Zeisel M.B., Cosset F.L., Baumert T.F. Host neutralizing responses and pathogenesis of hepatitis C virus infection. Hepatology 2008, 48(1):299-307.